Stock daily read

What happened with ENSG today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

ENSG in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

The Ensign Group’s subsidiaries care for people who need short-term rehabilitation or longer-term nursing care because of illness or complex medical needs. Skilled nursing facilities generate nearly all its revenue. They receive payments largely at agreed daily rates, with some therapies and other treatments billed separately. Medicaid is the largest payer, followed by Medicare; together these government healthcare programs provide most of the revenue. Insurers and patients also pay for care.

Earnings depend on how many beds are occupied, patients’ care needs and who pays their bills. More medically complex patients generally bring higher reimbursement, while Medicaid typically pays less than other sources. Hospital and physician referrals help fill beds, and the facilities need enough nurses, therapists and other care staff to deliver services. Arizona, California and Texas account for most of the company’s revenue.

Government payment rules and state Medicaid funding strongly shape the business. Facilities must maintain state licenses and the approvals needed to receive Medicare or Medicaid payments. State rules can also require prior approval for acquisitions, expansion or changes in bed capacity.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in ENSG’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

ENSG says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer
  • PACS Group and Ensign run similarly sized skilled nursing portfolios, so both depend heavily on Medicare and Medicaid payments for post-acute and long-term care. Watch PACS's revenue from these government programs for changes in the payment environment that also shapes Ensign's results.

  • National Healthcare Corp. competes with Ensign for short-stay rehabilitation patients and long-term nursing residents, with both earning revenue from skilled nursing care. NHC's nursing-facility quality ratings offer a concrete benchmark for the care reputation Ensign competes on.

  • Ensign pays CareTrust REIT rent for 104 operations as of December 31, 2025, making CareTrust a direct landlord rather than just another nursing-sector investment. CareTrust's broader rental business also depends on nursing operators earning enough from patient care to pay rent, so their rent-paying ability is the useful signal for Ensign's operating environment.

  • Encompass Health competes with Ensign for recovering patients: it earns revenue from nursing and rehabilitation in hospitals, while Ensign provides post-acute rehabilitation in skilled nursing facilities. Watch Encompass's patient discharges to gauge activity in this competing care setting.

  • American Healthcare REIT competes in nursing and rehabilitation services that overlap Ensign's, and shares directly in its senior health campuses' operating gains and losses rather than merely collecting rent. Its campuses combine senior housing and nursing care and charge market rents, making their operating performance the relevant comparison with Ensign's care businesses.

  • Omega Healthcare Investors depends on nursing tenants earning enough from patient care to pay it rent, tying its property business to the same care and reimbursement markets that shape Ensign's nursing margins. Those tenants' ability to cover rent is a signal of conditions facing nursing operators such as Ensign.

  • Sabra Healthcare REIT's rent income is exposed to the reimbursement and occupancy conditions that drive Ensign's nursing business: it held 210 skilled nursing and transitional-care properties as of December 31, 2025. Watch whether nursing tenants can cover rent from care revenue, rather than treating Sabra as a direct care-provider comparison.

  • The Pennant Group competes with Ensign by delivering nursing and therapy in patients' homes rather than nursing facilities, and both also operate senior living communities. Pennant receives payments from government programs, managed care and private-pay patients and residents; its home-health business is the part to watch for competition with Ensign's facility-based post-acute care.

Agenda

in 13 daysMon, Nov 2

  1. Time to be announced
    Major

    The Ensign Group, Inc. earningsThis company

    Ensign earns most of its revenue from skilled nursing facilities, and this report will show whether better occupancy and a richer mix of higher-acuity patients can outweigh pressure from staffing and other service costs.

in 20 daysMon, Nov 9

  1. Time to be announced

    CareTrust REIT, Inc earningsCTRE

    CareTrust REIT is the landlord for 104 Ensign operations, and its report will show whether nursing operators are earning enough from care to pay rent—a signal of the conditions Ensign faces.

  2. Time to be announced

    PACS Group, Inc. earningsPACS

    PACS Group, like Ensign, runs a large skilled nursing business; its Medicare and Medicaid revenue will show how government-program payments are supporting operators in this part of the care market.